Effectiveness of adalimumab for ambulatory ulcerative colitis patients after failure of infliximab treatment: a first “real-life” experience in primary gastroenterology centers in Italy

BACKGROUND: Adalimumab (ADA) is the key treatment for ulcerative colitis (UC) unresponsive or intolerant to standard treatments. Our aim was to assess the efficacy and safety of ADA in treating ambulatory UC patients in primary gastroenterology centers. METHODS: Fifteen patients (6 male, median age...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Tursi, Antonio, Elisei, Walter, Picchio, Marcello, Penna, Antonio, Forti, Giacomo, Giorgetti, Gian Marco, Faggiani, Roberto, Zampaletta, Costantino, Pelecca, Giorgio, Brandimarte, Giovanni
Format: Artigo
Jezik:Inglês
Izdano: Hellenic Society of Gastroenterology 2014
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4188935/
https://ncbi.nlm.nih.gov/pubmed/25331091
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki